NDT Pharmaceuticals Inc. (NDTP)
OTCMKTS · Delayed Price · Currency is USD
0.3700
-0.0477 (-11.42%)
At close: Sep 18, 2026
NDT Pharmaceuticals Market Cap
NDT Pharmaceuticals has a market cap or net worth of $70.69 million as of September 18, 2026. Its market cap has decreased by -58.32% in one year.
Market Cap
70.69M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.37
ChartMarket Cap Chart
Since October 21, 2011, NDT Pharmaceuticals's market cap has increased from 2.76M to 70.69M, an increase of 2,462.05%. That is a compound annual growth rate of 24.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 70.69M | -73.17% |
| Dec 31, 2025 | 263.50M | 3,007.18% |
| Dec 31, 2024 | 8.48M | -13.47% |
| Dec 28, 2023 | 9.80M | 1,785.32% |
| Dec 31, 2021 | 519.82K | -69.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 118.19M |
| HST Global | 91.93M |
| Nuo Therapeutics | 62.96M |
| Sangamo Therapeutics | 60.03M |
| Arch Biopartners | 44.48M |
| BetterLife Pharma | 39.82M |
| Cell Source | 33.97M |
| ProText Mobility | 31.21M |